A Novel Encoder Decoder Architecture with Vision Transformer for Medical Image Segmentation
Saroj Bala,
No information about this author
Kumud Arora,
No information about this author
R Jeevitha
No information about this author
et al.
Journal of Electronics Electromedical Engineering and Medical Informatics,
Journal Year:
2025,
Volume and Issue:
7(1), P. 176 - 186
Published: Jan. 8, 2025
Brain
tumor
image
segmentation
is
one
of
the
most
critical
tasks
in
medical
imaging
for
diagnosis,
treatment
planning,
and
prognosis.
Traditional
methods
brain
are
mostly
based
on
Convolution
Neural
Network
(CNN),
which
have
been
proved
very
powerful
but
still
limitations
to
effectively
capture
long-range
dependencies
complex
spatial
hierarchies
MRI
images.
Variability
shape,
size,
location
tumors
may
affect
performance
get
stuck
into
suboptimal
outcomes.
In
these
regards,
new
encoder-decoder
architecture
with
VisionTranscoder(ViT)
proposed,
enhance
detection
classification.
The
proposed
VisionTranscoder
exploits
a
transformer's
ability
modeling
global
context
through
self-attention
mechanisms,
providing
more
inclusive
interpretation
intricate
patterns
images
classification
by
capturing
both
local
features.
maintains
Vision
Transformer
its
encoder
processing
as
sequences
patches
often
outside
view
traditional
CNNs.
Then
map
rebuilt
at
high
level
fidelity
decoder
upsampling
skips
connections
maintain
detailed
information.
risk
overfitting
hugely
reduced
design
advanced
regularization
techniques
extensive
data
augmentation.
dataset
contains
7,023
human
images,
all
four
different
classes:
glioma,
meningioma,
no
tumor,
pituitary.
Images
from
'no
tumor'
class,
indicating
an
scan
without
any
detectable
were
taken
Br35H
.
results
show
efficiency
over
wide
set
scans,
producing
accuracy
98.5%
loss
0.05.
This
underlines
it
accurately
segment
classify
overfitting.
Language: Английский
Collaborative Healthcare Data Management Framework using Parallel Computing and the Internet of Things
D. Shamia,
No information about this author
M Ephin,
No information about this author
Pratibha S. Yalagi
No information about this author
et al.
Journal of Electronics Electromedical Engineering and Medical Informatics,
Journal Year:
2025,
Volume and Issue:
7(1), P. 187 - 196
Published: Jan. 9, 2025
Healthcare
data
management
has
become
a
critical
research
area,
primarily
driven
by
the
widespread
adoption
of
personal
health
monitoring
systems
and
applications.
These
generate
an
immense
volume
data,
necessitating
efficient
reliable
solutions
for
lossless
sharing.
This
article
introduces
Collaborative
Data
Management
Framework
(CDMF)
that
leverages
combined
strengths
parallel
computing
federated
learning.
The
proposed
CDMF
is
designed
to
achieve
two
primary
objectives:
reducing
computational
complexity
in
handling
ensuring
high
sharing
accuracy,
regardless
generation
rate.
framework
employs
streamline
scheduling
processing
acquired
at
various
intervals.
approach
minimizes
delays
operating
on
less
complex
algorithm,
making
it
suitable
high-frequency
generation.
Federated
learning,
other
hand,
plays
pivotal
role
verifying
distribution
maintaining
accuracy.
By
enabling
decentralized
learning
ensures
remains
local
devices
while
only
necessary
model
updates.
enhances
privacy
security,
consideration
healthcare
management.
It
are
verified
based
appropriate
requests
avoiding
latency
issues.
decentralizing
process,
as
raw
does
not
leave
systems.
cooperative
interaction
between
operates
cyclic
manner,
allowing
adapt
dynamically
increasing
intervals
varying
rates.
performance
validated
through
improvements
key
metrics.
First,
achieves
15.08%
enhancement
which
vital
integrity
reliability
during
transfers.
Second,
reduces
computation
9.48%,
even
when
maximum
results
highlight
framework’s
potential
revolutionize
addressing
dual
challenges
scalability
Language: Английский
Uncertainty-guided and cross-modality attention network for liver tumor segmentation and quantification via integrating dynamic MRI
Knowledge-Based Systems,
Journal Year:
2025,
Volume and Issue:
unknown, P. 113021 - 113021
Published: Jan. 1, 2025
Language: Английский
Harnessing Artificial Intelligence in Early Detection and Diagnosis of Alzheimer's Disease: Current and Future Applications
Alaa Abdelfattah,
No information about this author
Waseem Sajjad,
No information about this author
Imtiaz Ali Soomro
No information about this author
et al.
Indus journal of bioscience research.,
Journal Year:
2025,
Volume and Issue:
3(2), P. 199 - 212
Published: Feb. 25, 2025
Alzheimer's
Disease
(AD)
is
a
neurodegenerative
disorder
requiring
early
detection.
This
study
compares
AI
models—Convolutional
Neural
Networks
(CNN),
Support
Vector
Machines
(SVM),
and
Random
Forest
(RF)—in
analyzing
neuroimaging
data
(MRI,
PET)
to
enhance
AD
prediction
improve
diagnosis
using
machine
learning
techniques.
Through
the
application
of
multi-modal
in
form
genetic,
clinical,
data,
also
investigates
effectiveness
combining
different
types
predictability
models
for
diagnosis.
Feature
importance
analysis
was
performed
methods
like
SHAP
(SHAP
(Shapley
Additive
Explanations)
values
determine
most
important
variables
model
predictions,
e.g.,
certain
brain
regions
or
genetic
components.
The
generalizability
real-world
applicability
by
training
on
an
independent
dataset
representing
diverse
clinical
settings.
performance
each
assessed
variety
statistical
measures
accuracy,
precision,
recall,
F1-score,
Area
Under
Curve
(AUC).
findings
showed
that
CNN
better
compared
SVM
RF
all
metrics
with
highest
accuracy
(92%),
precision
(93%),
recall
(91%),
AUC
(0.95).
suggest
effectively
detects
subtle
patterns,
making
it
strong
tool
While
well,
superior
accuracy.
Cross-validation
confirmed
its
generalizability,
crucial
use.
Implementing
models,
especially
CNN,
may
enable
earlier
detection,
timely
interventions,
improved
patient
outcomes
Alzheimer’s
care.
References
Language: Английский
Recent Advancements in Neuroimaging‐Based Alzheimer's Disease Prediction Using Deep Learning Approaches in e‐Health: A Systematic Review
Health Science Reports,
Journal Year:
2025,
Volume and Issue:
8(5)
Published: May 1, 2025
ABSTRACT
Purpose
Alzheimer's
disease
(AD)
is
a
severe
neurological
that
significantly
impairs
brain
function.
Timely
identification
of
AD
essential
for
appropriate
treatment
and
care.
This
comprehensive
review
intends
to
examine
current
developments
in
deep
learning
(DL)
approaches
with
neuroimaging
diagnosis,
where
popular
imaging
types,
reviews
well‐known
online
accessible
data
sets,
describes
different
algorithms
used
DL
the
correct
initial
evaluation
are
presented.
Significance
Conventional
diagnostic
techniques,
including
medical
evaluations
cognitive
assessments,
usually
not
identify
stages
Alzheimer's.
Neuroimaging
methods,
when
integrated
have
demonstrated
considerable
potential
enhancing
diagnosis
categorization
AD.
models
received
significant
interest
due
their
capability
its
early
phases
automatically,
which
reduces
mortality
rate
cost
Method
An
extensive
literature
search
was
performed
leading
scientific
databases,
concentrating
on
papers
published
from
2021
2025.
Research
leveraging
techniques
such
as
magnetic
resonance
(MRI),
positron
emission
tomography,
functional
(fMRI),
so
forth.
The
complies
Preferred
Reporting
Items
Systematic
Reviews
Meta‐Analyses
(PRISMA)
guidelines.
Results
Current
show
CNN‐based
especially
those
utilizing
hybrid
transfer
frameworks,
outperform
conventional
methods.
employing
combination
multimodal
has
enhanced
precision.
Still,
challenges
method
interpretability,
heterogeneity,
limited
exist
issues.
Conclusion
considerably
improved
accuracy
reliability
neuroimaging.
Regardless
issues
accessibility
adaptability,
studies
into
interpretability
fusion
provide
clinical
application.
Further
research
should
concentrate
standardized
rigorous
validation
architectures,
understandable
AI
methodologies
enhance
effectiveness
methods
prediction.
Language: Английский
Enhancing Aspect-Based Sentiment Analysis Through Multi-Granularity Information Sharing
N Ilayaraja,
No information about this author
S. Yuvaraj,
No information about this author
Rini Chowdhury
No information about this author
et al.
Published: July 26, 2024
Language: Английский
Boundary Feature-Based Leaf Disease Detection Using Differential Network
Ankita Mitra,
No information about this author
P Ponnila,
No information about this author
S. Yuvaraj
No information about this author
et al.
Published: July 26, 2024
Language: Английский
Novel Automatic Classification of Human Adult Lung Alveolar Type II Cells Infected with SARS-CoV-2 through the Deep Transfer Learning Approach
Turki Turki,
No information about this author
Sarah Al Habib,
No information about this author
Y‐h. Taguchi
No information about this author
et al.
Mathematics,
Journal Year:
2024,
Volume and Issue:
12(10), P. 1573 - 1573
Published: May 17, 2024
Transmission
electron
microscopy
imaging
provides
a
unique
opportunity
to
inspect
the
detailed
structure
of
infected
lung
cells
with
SARS-CoV-2.
Unlike
previous
studies,
this
novel
study
aims
investigate
COVID-19
classification
at
cellular
level
in
response
Particularly,
differentiating
between
healthy
and
human
alveolar
type
II
(hAT2)
Hence,
we
explore
feasibility
deep
transfer
learning
(DTL)
introduce
highly
accurate
approach
that
works
as
follows:
First,
downloaded
processed
286
images
pertaining
hAT2
obtained
from
public
image
archive.
Second,
provided
two
DTL
computations
induce
ten
models.
The
first
computation
employs
five
pre-trained
models
(including
DenseNet201
ResNet152V2)
trained
on
more
than
one
million
ImageNet
database
extract
features
images.
Then,
it
flattens
output
feature
vectors
trained,
densely
connected
classifier
Adam
optimizer.
second
similar
manner,
minor
difference
freeze
layers
for
extraction
while
unfreezing
jointly
training
next
layers.
results
using
five-fold
cross-validation
demonstrated
TFeDenseNet201
is
12.37×
faster
superior,
yielding
highest
average
ACC
0.993
(F1
0.992
MCC
0.986)
statistical
significance
(P<2.2×10−16
t-test)
compared
an
0.937
0.938
0.877)
counterpart
(TFtDenseNet201),
showing
no
(P=0.093
t-test).
Language: Английский
WIMOAD: Weighted Integration of Multi-omics data for Alzheimer's Disease (AD) Diagnosis
Hanyu Xiao,
No information about this author
Jieqiong Wang,
No information about this author
Shibiao Wan
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 27, 2024
As
the
most
common
subtype
of
dementia,
Alzheimer's
disease
(AD)
is
characterized
by
a
progressive
decline
in
cognitive
functions,
especially
memory,
thinking,
and
reasoning
ability.
Early
diagnosis
interventions
enable
implementation
measures
to
reduce
or
slow
further
regression
disease,
preventing
individuals
from
severe
brain
function
decline.
The
current
framework
AD
depends
on
A/T/(N)
biomarkers
detection
cerebrospinal
fluid
imaging
data,
which
invasive
expensive
during
data
acquisition
process.
Moreover,
pathophysiological
changes
accumulate
amino
acids,
metabolism,
neuroinflammation,
etc.,
resulting
heterogeneity
newly
registered
patients.
Recently,
next
generation
sequencing
(NGS)
technologies
have
found
be
non-invasive,
efficient
less-costly
alternative
screening.
However,
existing
studies
rely
single
omics
only.
To
address
these
concerns,
we
introduce
WIMOAD,
weighted
integration
multi-omics
for
diagnosis.
WIMOAD
synergistically
leverages
specialized
classifiers
patients'
paired
gene
expression
methylation
multi-stage
classification.
scores
were
then
stacked
with
MLP-based
meta-models
performance
improvement.
prediction
results
two
distinct
integrated
optimized
weights
final
decision-making
model,
providing
higher
than
using
Remarkably,
achieves
significantly
alone
classification
tasks.
model's
overall
also
outperformed
approaches,
highlighting
its
ability
effectively
discern
intricate
patterns
their
correlations
clinical
results.
In
addition,
stands
out
as
biologically
interpretable
model
leveraging
SHapley
Additive
exPlanations
(SHAP)
elucidate
contributions
each
output.
We
believe
very
promising
tool
accurate
effective
biomarker
discovery
across
different
progression
stages,
eventually
will
consequential
impacts
early
treatment
intervention
personalized
therapy
design
AD.
Language: Английский